OpenResearchAlpha

bioRxiv · 20 Nov 2026

The tumor suppressor role of the KRAS proto-oncogene in metastatic pancreatic cancer.

Li Zhang, Enrico Gurreri, Haoyu Tang, Angelina Bania, Mohammad J. Ibrahim, Roberta Rinaldi, Aashta Pandey, Luca Cecchetto, Elisabetta Granato, Hania Khan, Anh Hoang, Desiree Catania, Calogero Carlino, Joseph R. Marszaleck, Chunhua Shi, Alessandro Sgambato, Giampaolo Tortora, Alessandro Carugo, Andrea Viale, Davide Cittaro, Stefano Sioletic, Laura Wood, David S. Klimstra, Olca Basturk, Shubam Pant, Milind Javle, Pavlos Msaouel, Jianjun Gao, Kadir C. Akdemir, Linghua Wang, Peter Van Loo, Francesca Citron, Timothy Heffernan, Christine A. Iacobuzio-Donahue, Scott Kopetz, Luigi Perelli, Giannicola Genovese

0
Citations
no database records one yet
0
Citations in 2026
so far
–
Leading author's h-index
no author has a profile yet
0
References
works it cites, from open citation data

Citations by database

Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.

  • OpenCitations0
  • Crossref0

Citations per year

The current year is still counting.

  • 2026 so far0

Abstract

KRAS is the most frequently mutated proto-oncogene in human cancers. Progression to advanced disease is frequently associated with allelic imbalance of the KRAS locus with gain of the mutant allele and loss of the wild-type allele through clonal and sub-clonal loss of heterozygosity (LOH). While a large body of literature has focused on the effects of allelic imbalance on oncogene addiction through gain of the mutant allele, the role of the wild-type KRAS proto-oncogene in malignant progression has not been fully elucidated. To capture this phenomenon, we developed a first-in-class somatic mosaic and lineage tracing genetically engineered mouse model (smGMLT) of pancreatic ductal adenocarcinoma allowing for real time in vivo tracing of Kras-LOH. Longitudinal characterization of the smGMLT demonstrated the presence of a strong evolutionary bottleneck towards the selective loss of the wild-type allele at metastatic sites. Cross species analysis leveraging research autopsies and surgical specimens revealed that KRAS-LOH is associated with metastatic dissemination and shorter overall survival. Transcriptomic analysis through single-cell RNA sequencing uncovered a conserved phenomenon whereby KRAS-LOH is paralleled by an immune evasive phenotype through loss of the tumor-cell interferon response and reduced CD8+ T cell infiltration. In line with this evidence, orthotopic transplants of isogenic tumor populations differing for the Kras allelic status demonstrated that only cancer cells with Kras-LOH are are able to form tumors in immune competent animals. Restoration of the wild-type allele abrogates tumorigenesis in KrasLOH transplants in immunocompetent through activation of the TBK1-IRF axis. Altogether, these studies demonstrate that the KRAS proto-oncogene is a functional tumor suppressor in pancreatic cancer exerting its function through interferon-mediated, cell-extrinsic modulation of the tumor immune microenvironment.

Cancer biology

What the data shows

  • No database records a citation yet, as is usual for a paper this new.

Graph

This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.

Citing paper shares an authorAuthor without a profileSize shows citations, or h-index for authors

Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.

Start with

Authors (37)

Each author's standing in QAI's scholar index: the works their ORCID iD is attached to, and for anyone whose ORCID record names a lab OpenResearch follows, their arXiv preprints matched by name and a shared co-author. Names are as printed on the paper.

ProfileMost-cited paper

Cited by 0 papers

Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.

0 shown
No citing papers for this filter.

References (0)

What it cites, from open citation data, with Crossref's record of each.

No references in the open citation data yet.
The tumor suppressor role of the KRAS proto-oncogene in metastatic pancreatic cancer. - QAI OpenResearch